Editors' ChoiceMedicine

Stressing Myc-driven cancer out

See allHide authors and affiliations

Science Translational Medicine  14 Feb 2018:
Vol. 10, Issue 428, eaar7535
DOI: 10.1126/scitranslmed.aar7535

Abstract

Myc-driven cancers can be targeted with the IRE1α inhibitor.

View Full Text

Stay Connected to Science Translational Medicine